This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 May 8;375(9726):1605-6; author reply 1606-7.

doi: 10.1016/S0140-6736(10)60696-4.

Procalcitonin in intensive care units: the PRORATA trial

Sébastien Gibot

PMID: 20452514
DOI: 10.1016/S0140-6736(10)60696-4

Comment

Procalcitonin in intensive care units: the PRORATA trial

Sébastien Gibot. Lancet. 2010.

. 2010 May 8;375(9726):1605-6; author reply 1606-7.

doi: 10.1016/S0140-6736(10)60696-4.

Author

Sébastien Gibot

PMID: 20452514
DOI: 10.1016/S0140-6736(10)60696-4

No abstract available

PubMed Disclaimer

Comment on

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M; PRORATA trial group. Bouadma L, et al. Lancet. 2010 Feb 6;375(9713):463-74. doi: 10.1016/S0140-6736(09)61879-1. Epub 2010 Jan 25. Lancet. 2010. PMID: 20097417 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information